Order Article Reprints

Inchingolo AD, Inchingolo AM, Bordea IR, Malcangi G, Xhajanka E, Scarano A, Lorusso F, Farronato M, Tartaglia GM, Isacco CG, et al. SARS-CoV-2 Disease Adjuvant Therapies and Supplements Breakthrough for the Infection Prevention. Microorganisms. 2021; 9(3):525. https://doi.org/10.3390/microorganisms9030525

Inchingolo, Alessio Danilo, Angelo Michele Inchingolo, Ioana Roxana Bordea, Giuseppina Malcangi, Edit Xhajanka, Antonio Scarano, Felice Lorusso, Marco Farronato, Gianluca Martino Tartaglia, Ciro Gargiulo Isacco, and et al. 2021. "SARS-CoV-2 Disease Adjuvant Therapies and Supplements Breakthrough for the Infection Prevention" Microorganisms 9, no. 3: 525. https://doi.org/10.3390/microorganisms9030525

Inchingolo, A. D., Inchingolo, A. M., Bordea, I. R., Malcangi, G., Xhajanka, E., Scarano, A., Lorusso, F., Farronato, M., Tartaglia, G. M., Isacco, C. G., Marinelli, G., D’Oria, M. T., Hazballa, D., Santacroce, L., Ballini, A., Contaldo, M., Inchingolo, F., & Dipalma, G. (2021). SARS-CoV-2 Disease Adjuvant Therapies and Supplements Breakthrough for the Infection Prevention. Microorganisms, 9(3), 525. https://doi.org/10.3390/microorganisms9030525